Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 190 | 0 | 0 | 0 | 0 |
| Gross Profit | 190 | N/A | N/A | N/A | N/A |
| Operating Expenses | 26,935 | 20,313 | 15,773 | 15,820 | 18,143 |
| Operating Income | -26,745 | -20,313 | -15,773 | -15,820 | -18,143 |
| Other Income | 999 | 781 | 892 | 852 | 882 |
| Pre-tax Income | -25,746 | -19,532 | -14,881 | -14,968 | -17,261 |
| Net Income Continuous | -25,746 | -19,532 | -14,881 | -14,968 | -17,261 |
| Minority Interests | 2 | 1 | 1 | 3 | 2 |
| Net Income | $-25,744 | $-19,531 | $-14,882 | $-14,975 | $-17,259 |
| EPS Basic Total Ops | -0.26 | -0.22 | -0.17 | -0.17 | -0.23 |
| EPS Basic Continuous Ops | -0.27 | -0.22 | -0.17 | -0.17 | -0.23 |
| EPS Diluted Total Ops | -0.26 | -0.22 | -0.17 | -0.17 | -0.23 |
| EPS Diluted Continuous Ops | -0.27 | -0.22 | -0.17 | -0.17 | -0.23 |
| EPS Diluted Before Non-Recurring Items | -0.26 | -0.22 | -0.17 | -0.18 | -0.23 |
| EBITDA(a) | $-26,868 | $-20,384 | $-15,913 | $-16,371 | $-18,364 |